Clinical trial
Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis
NCT03001323 is registered in ClinicalTrials.gov with Hennepin Healthcare Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis
- Lead sponsor
- Hennepin Healthcare Research Institute
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 31, 2017
- Completion date
- September 25, 2020
- Enrollment
- 27 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.